Angoorly Caroline
Known title: DirectorCIK: 0001348162
Associated companies
Transaction History
| ICFI | ▲ Buy | Grant | 2,277 | $0 | 7/1/2026 | View on chart |
| ICFI | ▲ Buy | Grant | 1,720 | $0 | 7/1/2025 | View on chart |
| ICFI | ▲ Buy | Grant | 444 | $0 | 4/1/2025 | View on chart |
| ICFI | ▲ Buy | Grant | 2,277 | $0 | 7/1/2026 | View on chart |
| ICFI | ▲ Buy | Grant | 1,720 | $0 | 7/1/2025 | View on chart |
| ICFI | ▲ Buy | Grant | 444 | $0 | 4/1/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
ICF International reports Q2 2026 results and receives rating upgrade
ICF International released its second-quarter 2026 earnings, a standard periodic update for the company. Following the report, the stock received a rating upgrade to Buy, signaling a shift in analyst sentiment. This development is relevant as the average analyst target price sits at $107.25, well above the current trading range. The news highlights ongoing interest in the company's performance within the business services sector.
ICF International reports Q2 2026 results and receives rating upgrade. ICF International released its second-quarter 2026 earnings, a standard periodic update for the company. Following the report, the stock received a rating upgrade to Buy, signaling a shift in analyst sentiment. This development is relevant as the average analyst target price sits at $107.25, well above the current trading range. The news highlights ongoing interest in the company's performance within the business services sector.